acebutolol has been researched along with Hypersensitivity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albanesi, M; Caiaffa, MF; Di Bona, D; Di Girolamo, A; Loconte, F; Macchia, L | 1 |
| Derry, D; Kathiresan, B; Waine, D | 1 |
| Gifford, AH | 1 |
| Hoo, ZH; Wildman, MJ | 1 |
| Anderson, GJ; Bell, SC; Lamont, IL; Masel, P; Reid, DW; Smith, DJ | 1 |
5 other study(ies) available for acebutolol and Hypersensitivity
| Article | Year |
|---|---|
Desensitization in Iron Product Allergy.
Topics: Adult; Anemia, Iron-Deficiency; Chlorpheniramine; Dexamethasone; Female; Ferric Compounds; Hematinics; Humans; Hypersensitivity; Iron; Maltose; Middle Aged; Skin Tests | 2020 |
The effect of intravenous antibiotics on anaemia in cystic fibrosis.
Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose | 2013 |
Hemoglobin ≤ 12.9 g/dl predicts risk of antibiotic treatment in cystic fibrosis.
Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose | 2014 |
Intravenous iron among cystic fibrosis patients.
Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Infusions, Intravenous; Iron; Lung Diseases; Maltose; Retrospective Studies | 2012 |
Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation.
Topics: Anemia, Iron-Deficiency; Cystic Fibrosis; Ferric Compounds; Humans; Hypersensitivity; Lung Diseases; Maltose | 2013 |